TGTX TG Therapeutics
- 34.800
- -0.200-0.57%
- 34.810
- +0.010+0.03%
TG Therapeutics News
TG Therapeutics | 10-Q: Q3 2024 Earnings Report
TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance
TG Therapeutics | 10-Q: Q2 2024 Earnings Report
TG Therapeutics | 10-K/A: Annual report (Amendment)
TG Therapeutics | 8-K: ® TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance
TG Therapeutics | 10-Q: Q1 2024 Earnings Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
TG Therapeutics | 10-K: FY2023 Annual Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
TG Therapeutics | 10-Q: Q3 2023 Earnings Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
TG Therapeutics | 10-Q: Q2 2023 Earnings Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
TG Therapeutics | 10-Q: Q1 2023 Earnings Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
TG Therapeutics | 10-K: FY2022 Annual Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
TG Therapeutics | 10-Q: Q3 2022 Earnings Report
TG Therapeutics | 10-Q: Q2 2022 Earnings Report
Analysis
Price Target
No Data
No Data